🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07133451
Starting soon Observational

Multimodal Imaging Evaluation of Vulnerability of Atherosclerotic Plaques: A Comparison of HR-VWI, OCT, and RWS

NCT07133451 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase
Observational
Started
2025-08-10
Last updated
2025-08-21

Condition(s) studied

Intracranial Atherosclerotic Stenosis

Study summary

The primary objective of this study is to evaluate the vulnerability of intracranial and extracranial atherosclerotic plaques using HR-VWI, OCT, and RWS technologies, while exploring correlations among these three imaging techniques. Secondary objectives include: 1) Investigating the relationship between RWS and plaque progression and identifying optimal RWS predictors; 2) Further evaluating the clinical value of RWS and HR-VWI in stroke prediction through two-year clinical and HR-VWI follow-up evaluations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * At least 18 years old; * Severe stenosis of intracranial arteries (stenosis degree: 70% \~ 99%, traditional angiography is required to confirm the degree of stenosis according to the criteria of Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) study); * Carry out cerebral angiography and OCT within one week after HR-VWI examination; * The patient or the legal representative of the patient is able and willing to sign an informed consent form. Exclusion Criteria: * Non-atherosclerotic intracranial and extracranial artery stenosis, such as dissection, smoke disease, etc.; * There are contraindications to MRI, such as claustrophobia, metal implants, etc.; Renal insufficiency, elevated serum creatinine (more than twice the upper limit of normal); * Patients with severe cardiopulmonary diseases were considered unsuitable for this study; * Allergy to iodine or gadolinium contrast agent; * Participants who were unable to complete the study due to mental illness, cognitive or emotional disorder.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai 6th People's Hospital Shanghai China

More Shanghai Jiao Tong University Affiliated Sixth People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07133451 on ClinicalTrials.gov ↗ ← All trials in China